色噜噜人体337p人体 I 超碰97观看 I 91久久香蕉国产日韩欧美9色 I 色婷婷我要去我去也 I 日本午夜a I 国产av高清怡春院 I 桃色精品 I 91香蕉国产 I 另类小说第一页 I 日操夜夜操 I 久久性色 I 日韩欧在线 I 国产深夜在线观看 I 免费的av I 18在线观看视频 I 他也色在线视频 I 亚洲熟女中文字幕男人总站 I 亚洲国产综合精品中文第一 I 人妻丰满熟av无码区hd I 新黄色网址 I 国产精品真实灌醉女在线播放 I 欧美巨大荫蒂茸毛毛人妖 I 国产一区欧美 I 欧洲亚洲1卡二卡三卡2021 I 国产亚洲欧美在线观看三区 I 97精品无人区乱码在线观看 I 欧美妇人 I 96精品在线视频 I 国产人免费视频在线观看 I 91麻豆国产福利在线观看

雅思閱讀模擬試題參考

時間:2021-06-10 19:14:49 試題 我要投稿

雅思閱讀模擬試題參考

  1. The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels. But many researchers remain confident that drugs to boost levels of ’good’ cholesterol are still one of the most promising means to combat spiralling heart disease.

雅思閱讀模擬試題參考

  2. Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib, a drug designed to raise heart-protective high-density lipoproteins (HDLs)。 In a trial of 15000 patients, a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone.

  3. The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease. There have been no red flags to my knowledge, says John Chapman, a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib. This cancellation came as a complete shock.

  4. Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs, which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body. Specifically, torcetrapib blocks a protein called cholesterol ester transfer protein (CETP), which normally transfers the cholesterol from high-density lipoproteins to low density, plaque-promoting ones. Statins, in contrast, mainly work by lowering the ’bad’ low-density lipoproteins.

  Under pressure

  5. Researchers are now trying to work out why and how the drug backfired, something that will not become clear until the clinical details are released by Pfizer. One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients. It was thought that this mild problem would be offset by the heart benefits of the drug. But it is possible that it actually proved fatal in some patients who already suffered high blood pressure. If blood pressure is the explanation, it would actually be good news for drug developers because it suggests that the problems are specific to this compound. Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall.

  6. But it is also possible that the whole idea of blocking CETP is flawed, says Moti Kashyap, who directs atherosclerosis research at the VA Medical Center in Long Beach, California. When HDLs excrete cholesterol in the liver, they actually rely on LDLs for part of this process. So inhibiting CETP, which prevents the transfer of cholesterol from HDL to LDL, might actually cause an abnormal and irreversible accumulation of cholesterol in the body. You’re blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway, says Kashyap.

  Going up

  7. Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug, called niacin, is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by, for example, introducing synthetic HDLs. The only thing we know is dead in the water is torcetrapib, not the whole idea of raising HDL, says Michael Miller, director of preventive cardiology at the University of Maryland Medical Center, Baltimore.

  (613 words nature)

  Questions 1-7

  This passage has 7 paragraphs 1-7.

  Choose the correct heading for each paragraph from the list of headings below.

  Write the correct number i-ix in boxes 1-7 on your answer sheet.

  List of Headings

  i. How does torcetrapib work?

  ii. Contradictory result prior to the current trial

  iii. One failure may possibly bring about future success

  iv. The failure doesn’t lead to total loss of confidence

  v. It is the right route to follow

  vi. Why it’s stopped

  vii. They may combine and theoretically produce ideal result

  viii. What’s wrong with the drug

  ix. It might be wrong at the first place

  Example answer

  Paragraph 1 iv

  1. Paragraph 2

  2. Paragraph 3

  3. Paragraph 4

  4. Paragraph 5

  5. Paragraph 6

  6. Paragraph 7

  Questions 7-13

  Match torcetrapib,HDLs,statin and CETP with their functions (Questions 8-13)。。

  Write the correct letter A, B, C or D in boxes 8-13 on your answer sheet.

  NB You may use any letter more than once.

  7.It has been administered to over 10,000 subjects in a clinical trial.

  8.It could help rid human body of cholesterol.

  9.Researchers are yet to find more about it.

  10. It was used to reduce the level of cholesterol.

  11. According to Kashyap, it might lead to unwanted result if it’s blocked.

  12. It produced contradictory results in different trials.

  13. It could inhibit LDLs.

  List of choices

  A. Torcetrapic

  B. HDLS

  C. Statin

  D. CETP

  (by Zhou Hong)

  Suggested Answers and Explanations

  1. vi

  2. ii

  3. vii 本段介紹了torcetrapib和statin的治病原理,但是同時短語in contrast與之前第二段后半段的內容呼應,暗示了這兩種藥在理論上能相輔相成,是理想的搭配。第一個選項無法涵蓋整段意義,故選擇i是錯誤的。

  4. iii 本段分析了可能導致torcetrapibl臨床試驗失敗的原因,后半段指出如果以上推測正確,那么未來的藥物可借鑒這個試驗,設法避免torcetrapib的缺陷,研制出有效的'藥物。viii選項無法涵蓋后半段的意思。

  5. ix 見首句。

  6. v

  7. A 見第二段。題目中administer一詞意為用藥,subject一詞為實驗對象之意。

  8. B 見第四段… to raise levels of HDLs, which ferry cholesterol out of artery- clogging plaques to the liver for removal from the body.即HDLs的作用最終是將 choleserol清除出人體:… for removal from the body。

  9. B 見第四段But HDLs are complex and not entirely understood.

  10. C 見第二段… plus a cholesterol-lowering statin,即statin是可以降低cholesterol的。

  11. D 見第六段 So inhibiting CETP, … might actually cause an abnormal and irreversible accumulation of cholesterol in the body.

  12. A 見第三段。

  13. C 見第四段Statins, in contrast, mainly work by lowering the ’bad’ low-density lipoproteins.

【雅思閱讀模擬試題參考】相關文章:

雅思歷年閱讀模擬試題04-01

雅思閱讀模擬練習試題及答案11-26

雅思模擬閱讀習題06-14

雅思聽力模擬試題練習03-19

科學模擬試題參考06-11

模擬試題及答案參考06-13

雅思閱讀模擬練習題06-14

雅思閱讀經典模擬題06-13

關于雅思閱讀模擬習題及答案12-27

主站蜘蛛池模板: 欧美激情ⅹxx免费视频 | 人人澡人人爽夜欢视频 | 国产在线精品一区二区不卡麻豆 | 国产成人年无码av片在线观看 | 蜜桃91丨九色丨蝌蚪91桃色 | 亚洲国产成人无码专区 | 色一情一乱一伦一区二区三区 | 无遮挡刺激视频 | 辣+高h+浓+np+肉+黄在线 | 精品精品国产理论在线观看 | 搡少妇在线视频少妇干活了 | 免费看色片网站 | 老司机午夜福利视频 | 东北妇女精品bbwbbw | 尤物一区二区三区 | 自拍偷拍亚洲激情 | 欧美成在线视频 | 欧美性精品| 国产午夜亚洲精品午夜鲁丝片 | 国产欧美日韩精品丝袜高跟鞋 | 无套内谢老熟女 | 黄网在线免费 | 免费毛片在线播放 | 久久久av网站 | 97久久超碰国产精品旧版 | av无码爆乳护士在线播放 | 免费观看在线毛片 | av免费网址| 国产成久久免费精品av片 | 99999视频| 亚洲图片欧美在线看 | 日本黄网站三级三级三级 | 亚洲色成人网站www永久男男 | 国产女人高潮呻吟抽搐 | 狠狠干女人| 一本色道无码道在线观看 | 亚洲国产成人精品无码区在线秒播 | 国内少妇毛片视频 | 日日夜夜骑 | 一道本在线伊人蕉无码 | 无码欧美毛片一区二区三 | 人人艹超碰 | 国内精品久久久久久 | 国产偷窥老熟盗摄视频 | 在线喷水 | 欧洲亚洲日韩性无码专区 | 6080成人 | 婷婷一区二区三区 | na体内裑精亚洲日本 | 99国产成人综合久久精品77 | 激情内射亚洲一区二区三区 | 国产成熟人妻换╳╳╳╳ | 免费国产黄网站在线观看动图 | 久久久综合九色综合鬼色 | 久久国产精品免费专区 | 欧美综合成人网 | 国产女人高潮的av毛片 | 中文字幕av久久爽一区 | 羞羞的视频在线 | 日本乱码一区二区 | 婷婷国产天堂久久综合亚洲 | 亚洲成a人片在线观看无码专区 | 呦小性13一14xxxxhd | 亚洲操你| 久久欧美亚洲另类专区91大神 | 九九99精品 | 天堂一区人妻无码 | 黄色二级毛片 | 精品深夜寂寞黄网站 | 天天色av| 少妇高潮喷潮久久久影院 | 日韩在线精品强乱中文字幕 | 看污片网站 | 草的我好爽视频 | 国产欧美亚洲精品a第一页 中文字幕在线一区 | 四虎成人欧美精品在永久在线 | 99这里有精品视频视频 | 和搜子同居的日子2在线 | 国产成人综合久久精品推最新 | 精品9e精品视频在线观看 | a一区二区三区乱码在线 | 欧洲 | mm1313亚洲国产精品无码试看 | 日韩在线综合视频 | 午夜免费毛片 | 色两性网欧美 | 欧美日韩免费一区中文 | 国产aaa精品 | 午夜精品乱人伦小说区 | 亚洲一卡2卡3卡4卡5卡乱码观看 | 永久免费的av片在线电影网 | 亚洲精品无码伊人久久 | 精品国产资源 | 人妻熟女斩五十路0930 | 国产片精品av在线观看夜色 | 午夜精品久久久久久久男人的天堂 | 日韩免费高清大片在线 | 国产精品久久久久久无码五月 | 久久天天躁狠狠躁夜夜2020老熟妇 | 亚洲另类色综合网站 |